ollicular thyroid carcinoma (FTC) is the second most common thyroid malignancy and accounts for approximately 10% of all thyroid malignancies.
A 52-year-old man was referred for sonographic examination to evaluate a hypermetabolic lesion that suggested metastasis in his left neck. He had undergone total thyroidectomy and cervical lymph node sampling because of 4-cm widely invasive FTC at an outside hospital. No cervical lymph node metastasis was observed. The patient then received radioactive iodine ablation therapy with 200 mCi. During the follow-up period, his serum thyroglobulin (Tg) level was maintained within normal ranges, but 4 years 9 months after the surgery, it was elevated at 861 ng/mL. Outside [ A neck sonographic examination was performed to evaluate the hypermetabolic lesion, and it showed a round, mainly hyperechoic mass within his left IJV ( Figure 3A) . His left IJV was partially occluded by the mass, and there was no other suspicious extravascular lesion at the level of the mass. On a color Doppler image, there was a color signal within the mass ( Figure 3B ).
Sonographically guided FNAB of the intravascular mass was performed, and the aspirated specimen showed numerous clusters of microfollicle-forming atypical cells, which suggested metastatic FTC ( Figure 4A ). A wide excision of the left IJV containing the intravascular mass was performed, and the mass was finally confirmed to be hematogenously metastatic FTC ( Figure  4B ). On follow-up neck sonography, there was no evidence of recurrence at the operation site, and his serum Tg level was 6.8 ng/mL 8 months later because of the residual bony lesion.
Discussion
Follicular thyroid carcinoma is generally considered a more aggressive tumor than papillary thyroid cancer, 1 and PTC and FTC carry 10-year overall survival rates of 93% and 85%, respectively. 2 Lymph node metastases are uncommon in patients with FTC, occurring in approximately 10%, whereas approximately 50% of patients with PTC have at least microscopic lymph node metastases. In addition, distant pulmonary or bone metastases are more common in patients with FTC (30%) compared to those with PTC (15%). 1 Clinical presentations of FTC are diverse and range from skull masses to bulbar palsy. 3 Follicular cancer occurs more often in women, and the female to male ratio is 3:1. The mean age at presentation is 50 years, and it is more common in areas of iodine deficiency. 4 Histopathologically, the recent World Health Organization classification of tumors divided follicular carcinomas into 2 major categories, according to their degree of invasiveness, as follows: minimally and widely invasive follicular carcinoma. 5 Minimally invasive follicular carcinomas have limited capsular and vascular invasion, whereas widely invasive follicular carcinomas have widespread infiltration of adjacent thyroid tissues and blood vessels. 5 Van Heerden et al 6 reported that only distant metastasis at diagnosis had independent prognostic significance (P < .0001) in the prediction of causespecific mortality. According to their report, there had been no cancer-related mortality and no distant metastasis in 20 patients who had surgically treated minimally invasive FTC during a mean 10-year follow-up period, and the vascular invasion increased the disease-specific mortality at 10 years to 28%. 6 The probability of aggressive behavior increases with the extent of vascular invasion because of the greater probability of recurrence and metastases caused by angioinvasion; therefore, the risk of metastatic disease in patients with widespread vascular invasion is substantial. 5, 7 The tumor type of our patient was a widely invasive follicular carcinoma, which suggested that he was at risk of metastasis. Additionally, Lo et al 7 had reported that older patients (men ≥40 and women ≥50 years) had a greater risk (10.4 times) than younger patients. The International Union Against Cancer/ American Joint Committee on Cancer pTNM staging system also considers the age at presentation (45 years, any sex) and adopted size criteria as relevant to cancer-specific survival.
8 Our patient was a man, and his age at presentation was 47 years, which presented an additional risk factor.
Distant metastasis in differentiated thyroid cancer can be divided into 2 categories: distant metastasis as the initial diagnosis and distant A B Figure 4 . A, Cytologic specimen shows many clusters of microfollicle-forming atypical cells, suggestive of a follicular neoplasm (hematoxylin-eosin, original magnification ×400). B, Histologically, the tumor cells proliferate, forming well-developed follicles or solid nests. They invade to the venous walls aggressively (arrow), which is shown by the positivity of smooth muscle actin immunostaining (inset, arrowhead; original magnifications ×40 and ×100, respectively).
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metastasis after initial treatment of thyroid cancer. The most frequent site of metastatic disease is either the lungs or bones, 2,9 and there have been few reports regarding skeletal or skin metastases diagnosed by FNAB. 10, 11 According to these reports, FNAB is a useful diagnostic tool for metastatic FTC, but it is difficult to diagnose follicular neoplasms by FNAB. 3, [10] [11] [12] This case was unique because it was a hematogenously metastasizing intravascular mass from FTC and not from a direct invasion, and it was a delayed metastasis. There was a report of thyroid insular carcinoma with jugular vein invasion, but it was different from our case because of its timing and cell type. 13 The reported case was an initial metastatic lesion, and it was a locally aggressive mass, but this case involved delayed metastasis. On sonography, this metastatic lesion showed echogenicity and characteristics similar to those of benign-looking thyroid nodules, which provided a clue for diagnosis.
In summary, FTC can metastasize into the vascular lumen and not by direct invasion. An initial large tumor size, a widely invasive type, and age older than 40 years in men, could be risk factors for metastasis.
